SEC 13F Intelligence

Enavate Sciences GP, LLC / SION

Enavate Sciences GP, LLC’s Sionna Therapeutics Inc Position

Does Enavate Sciences GP, LLC own Sionna Therapeutics Inc (SION)? Yes — 2.48M shares worth $99M (+28.26% of its 13F portfolio) as of Q1 2026.

Position Value
$99M
Q1 2026
Shares
2.48M
% of Portfolio
+28.26%
Quarters Held
5
currently held

Position History SION

Reported value by quarter
Q1 ’25: $26MQ1 ’25Q2 ’25: $43MQ2 ’25Q3 ’25: $73MQ3 ’25Q4 ’25: $102MQ4 ’25Q1 ’26: $99MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.48M$99M+28.26%
Q4 20252.48M$102M+20.12%
Q3 20252.48M$73M+22.25%
Q2 20252.48M$43M+24.35%
Q1 20252.48M$26M+19.53%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Enavate Sciences GP, LLC’s full portfolio or all institutional holders of SION.